• SANEMUS AG

    We are looking forward to your inquiry!

  • SANEMUS AG

    Your competent partner in the Life Science sector!

About us

SANEMUS AG focuses on investing in company and asset shares in the German healthcare market and offers strategic, financial and merger&acquisition advisory in this context. It was founded in 2006 by experienced healthcare professionals in Munich. The investment focus is exclusively put on the Life Science sector with its submarkets pharmaceutical industry, biotechnology, medical technology, diagnostics and E-health.

Our Mission

We assist to develop commercially attractive companies from promising Start-Ups from the Life Science sector due to the complementary strategic and financial advisory services offered.

We provide strategic input to substantially increase the value of Life Science companies by sophisticated lifecycle und portfolio management as well as strategic partnering.

We advise investors in Life Science investments – either in single investment projects or in Venture Capital or Private Equity Funds – to achieve an individually optimal value increase of their investments.

Current news

Venture capital in the German life-science-industry - part 2: Role of life-science-corporate-venture-fonds in innovation strategy of pharma-/biotechnology companies

Dr. Michael Thiel published the second part of the three-part series on venture capital in the German life-science-industry. The article focuses on the role of life-science-corporate-venture-fonds for the innovation strategy of pharma and biotechnology…

New treatment option for cART-resistant HIV patients

SANEMUS supports a German biotech start-up in searching venture capital. With its innovative, patented compound, the company offers a completely new therapeutic approach for the treatment of HIV patients who are resistant to therapy. Initial…

Tele-monitoring solution for Parkinson’s Disease patients

SANEMUS supports a telemedicine start-up in fundraising. The start-up has developed a telemedicine system for the adjustment of medication of Parkinson's Disease patients at home. After a successful test phase in inpatient and outpatient care,…

New board of directors for SANEMUS

SANEMUS has a new board of directors. Chairman is Dr. Theo Trucksaess assisted by Dr. Dr. Michael Dahm and Bernd Seibel.  Dr. Theo Trucksaess is European Partner of Shentou Investment Co. Ltd. Dr. Dr. Michael Dahm is CMO of ORYX GmbH…
Partners
BVK- Bundesverand Deutscher Kapitalbeteiligungsgesellschaften
Going Public - Das Kapitalmarkt-Portal
Forum MedTech Pharma